The self-driving UV disinfection robots are being sent to more than 2000 hospitals.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
FDA, CDC and other agencies are trying to foster the development of diagnostics, therapeutics and vaccines that help address the outbreak.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
This major health threat is driving demand for more diagnostic tests and devices to treat cardiac problems.
Digital reality technologies are fast emerging as promising tools to aid physicians and patients. Western and Asian medtech companies are becoming big players in the growing market for these new applications in Asia.
The race to apply AI to medical treatment is rapidly accelerating in China and Japan.
Regional demand for more equipment and sophisticated treatment is expected to grow.